The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 19, 2009
Filed:
Feb. 26, 2001
Arthur B. Raitano, Los Angeles, CA (US);
Daniel E. H. Afar, Brisbane, CA (US);
Gazelle S. Rastegar, Beverly Hills, CA (US);
Steve Chappell Mitchell, Santa Monica, CA (US);
Rene S. Hubert, Los Angeles, CA (US);
Pia M. Challita-eid, Encino, CA (US);
Mary Faris, Los Angeles, CA (US);
Aya Jakobovits, Beverly Hills, CA (US);
Arthur B. Raitano, Los Angeles, CA (US);
Daniel E. H. Afar, Brisbane, CA (US);
Gazelle S. Rastegar, Beverly Hills, CA (US);
Steve Chappell Mitchell, Santa Monica, CA (US);
Rene S. Hubert, Los Angeles, CA (US);
Pia M. Challita-Eid, Encino, CA (US);
Mary Faris, Los Angeles, CA (US);
Aya Jakobovits, Beverly Hills, CA (US);
Agensys, Inc., Santa Monica, CA (US);
Abstract
A novel gene (designated 103P2D6) and its encoded protein are described. 103P2D6 is not expressed in normal adult tissue, but is highly expressed in prostate tissue xenografts, providing evidence that it is turned on in prostate cancer. 103P2D6 is also expressed in some fetal tissues, and in breast, bladder, lung, bone, colon, pancreatic, testicular, cervical and ovarian cancers. Consequently, 103P2D6 provides a diagnostic and/or therapeutic target for cancers, and the 103P2D6 gene or fragment thereof, or its encoded protein or a fragment thereof can be used to elicit an immune response.